Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.

M.M.J. van Eijk; K.C.B. Roes; M.L. Honing; M. Kuiper; A. Karakus; M. van der Jagt; P.E. Spronk; W.A. van Gool; R.C. van der Mast; J. Kesecioglu; A.J.C. Slooter

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.

M.M.J. van Eijk
, K.C.B. Roes
, M.L. Honing
, M. Kuiper
, A. Karakus
, M. van der Jagt
, P.E. Spronk
, W.A. van Gool
, R.C. van der Mast
, J. Kesecioglu
, A.J.C. Slooter

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1829-1837
Number of pages	9
Journal	The Lancet
Volume	376
Issue number	9755
Publication status	Published - 2010

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21056464

Cite this

van Eijk, M. M. J., Roes, K. C. B., Honing, M. L., Kuiper, M., Karakus, A., van der Jagt, M., Spronk, P. E., van Gool, W. A., van der Mast, R. C., Kesecioglu, J., & Slooter, A. J. C. (2010). Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. The Lancet, 376(9755), 1829-1837. http://www.ncbi.nlm.nih.gov/pubmed/21056464

@article{b86a3ae4cec54741b614297e9b55a3a4,

title = "Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.",

author = "\{van Eijk\}, M.M.J. and K.C.B. Roes and M.L. Honing and M. Kuiper and A. Karakus and \{van der Jagt\}, M. and P.E. Spronk and \{van Gool\}, W.A. and \{van der Mast\}, R.C. and J. Kesecioglu and A.J.C. Slooter",

year = "2010",

language = "English",

volume = "376",

pages = "1829--1837",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9755",

}

van Eijk, MMJ, Roes, KCB, Honing, ML, Kuiper, M, Karakus, A, van der Jagt, M, Spronk, PE, van Gool, WA, van der Mast, RC, Kesecioglu, J & Slooter, AJC 2010, 'Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.', The Lancet, vol. 376, no. 9755, pp. 1829-1837. <http://www.ncbi.nlm.nih.gov/pubmed/21056464>

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. / van Eijk, M.M.J.; Roes, K.C.B.; Honing, M.L. et al.
In: The Lancet, Vol. 376, No. 9755, 2010, p. 1829-1837.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.

AU - van Eijk, M.M.J.

AU - Roes, K.C.B.

AU - Honing, M.L.

AU - Kuiper, M.

AU - Karakus, A.

AU - van der Jagt, M.

AU - Spronk, P.E.

AU - van Gool, W.A.

AU - van der Mast, R.C.

AU - Kesecioglu, J.

AU - Slooter, A.J.C.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0140-6736

VL - 376

SP - 1829

EP - 1837

JO - The Lancet

JF - The Lancet

IS - 9755

ER -